FindTrial
Sign In

WB-MRI

DIAGNOSTIC_TEST5 trials

Sponsors

Herlev Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Royal Marsden NHS Foundation Trust, Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS, European Institute of Oncology

Conditions

Advanced Prostate CancerMetastatic Breast CancerMetastatic Castration Resistant Prostate Cancer (mCRPC)Prostate CancerProstate Cancer Metastatic to Bone

Phase 1

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy
TerminatedNCT03619655
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsProstate Cancer
Start: 2019-11-15End: 2022-11-14Updated: 2023-10-31

Unknown Phase

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients
NCT03134261
Herlev HospitalProstate Cancer Metastatic to Bone
Start: 2014-04-30End: 2018-04-30Target: 300Updated: 2017-05-05
Whole Body Magnetic Resonance Imaging Study
NCT04117594
Royal Marsden NHS Foundation TrustAdvanced Prostate Cancer
Start: 2019-10-09End: 2021-06-30Target: 50Updated: 2021-05-19
The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)
TerminatedNCT05208229
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSMetastatic Castration Resistant Prostate Cancer (mCRPC)
Start: 2021-02-01End: 2022-03-08Updated: 2025-04-01
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
Active, not recruitingNCT06321666
European Institute of OncologyMetastatic Breast Cancer
Start: 2019-09-12End: 2024-12-31Updated: 2024-03-20